Prodrug based optimal drug delivery via membrane transporter/receptor.
about
Sodium dependent multivitamin transporter (SMVT): a potential target for drug deliveryPathways for small molecule delivery to the central nervous system across the blood-brain barrier.Targeting approaches to oral drug delivery.Current prodrug strategies via membrane transporters/receptors.Drug delivery to the retina: challenges and opportunities.Update on emerging antivirals for the management of herpes simplex virus infections: a patenting perspective.Chemical modification and formulation approaches to elevated drug transport across cell membranes.Exploitation of bile acid transport systems in prodrug design.Prodrug approaches for CNS deliveryModeling kinetics of subcellular disposition of chemicals.Current and emerging antivirals for the treatment of cytomegalovirus (CMV) retinitis: an update on recent patents.Advances in ocular drug delivery: emphasis on the posterior segment.Enhancing the buccal mucosal delivery of peptide and protein therapeutics.Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery.Challenges in nasal drug absorption: how far have we come?Transport and killing mechanism of a novel camptothecin-deoxycholic acid derivate on hepatocellular carcinoma cells.Differential expression of folate receptor-alpha, sodium-dependent multivitamin transporter, and amino acid transporter (B (0, +)) in human retinoblastoma (Y-79) and retinal pigment epithelial (ARPE-19) cell lines.Targeting SVCT for enhanced drug absorption: synthesis and in vitro evaluation of a novel vitamin C conjugated prodrug of saquinavir.Engineering cytochrome-modified silica nanoparticles to induce programmed cell death.Self-assembling prodrugs.
P2860
Q26863420-29BF3B4C-286A-46DB-8EA0-0C57C19E248BQ33783748-274EC7EC-85BF-4B37-AD08-D2032149AA62Q34482068-0DC5377B-E291-4A7D-B20E-39533A808E2DQ34779782-0CF82BDA-8AF2-444B-9CE1-B92DDEB9CA7CQ35116140-C2678C50-375B-448D-BCDF-C70FBC35214DQ35531731-7AB13792-0FE2-4025-8A7D-927D08C27144Q36527751-D64E461D-524F-4CBB-AF6B-7866280B3B3EQ36981149-67BB35EE-BAD3-49EF-8B7C-DEDDC486F50EQ37150860-4C1F16B2-6FDF-420B-B5D5-998AD99F456CQ37194304-63C024C7-BF8A-48E4-B83B-3AABBE6DD528Q37951633-984B6942-2051-4ADD-9C55-7152A102AB82Q38224320-05089199-4CDE-45B3-9B79-281F7C0E8A72Q38244323-9F5B5618-B1B0-4177-941F-A6FD0FDF93BFQ38708393-C873C9C4-37F0-408B-826E-542C1485D206Q38842805-903A70ED-4111-4CC5-8566-E1B475010482Q39005112-5F62C2A1-2822-4977-B14E-6AA19F27860BQ39401864-78509E5A-184A-4F1C-9E41-0E3AF823FAC4Q39542690-44836E89-8B00-4DC0-AA6F-E76D47879FC8Q42097977-2C2520B6-8FAB-45DF-B650-3D9B45ACB592Q47904111-75401661-DC44-4E09-B579-F8D0D458CA9D
P2860
Prodrug based optimal drug delivery via membrane transporter/receptor.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Prodrug based optimal drug delivery via membrane transporter/receptor.
@ast
Prodrug based optimal drug delivery via membrane transporter/receptor.
@en
Prodrug based optimal drug delivery via membrane transporter/receptor.
@nl
type
label
Prodrug based optimal drug delivery via membrane transporter/receptor.
@ast
Prodrug based optimal drug delivery via membrane transporter/receptor.
@en
Prodrug based optimal drug delivery via membrane transporter/receptor.
@nl
prefLabel
Prodrug based optimal drug delivery via membrane transporter/receptor.
@ast
Prodrug based optimal drug delivery via membrane transporter/receptor.
@en
Prodrug based optimal drug delivery via membrane transporter/receptor.
@nl
P2093
P2860
P356
P1476
Prodrug based optimal drug delivery via membrane transporter/receptor.
@en
P2093
P2860
P304
P356
10.1517/14712598.1.2.159
P407
P577
2001-03-01T00:00:00Z